APP Pharmaceuticals has bought additional facilities at a site in Grand Island, New York seizing the opportunity created by Astellas Manufacturing’s decision to shift production of its dermatitis drug Protopic to Japan.
Pall Life Sciences gave Outsourcing-Pharma.com an update on its
budding operations in India, one of the most promising markets for
the firm, where the pharmaceutical industry is growing at a rate of
nearly 9 per cent annually.
Predictions that the generics industry will experience further
consolidation - made at the annual meeting of the International
Generic Pharmaceutical Alliance this week - have been swiftly
followed by the news that Sandoz is buying...
Japan's Taiyo Pharmaceutical Industry is planning to increase its
contract manufacturing operations in the wake of new government
legislation that makes it easier for firms to produce drugs for